EUVIMEDEUVIMED entdecken
Netzwerk-MetaanalyseSystematische Übersicht

Efficacy and safety of pharmacological interventions for the maintenance of bipolar disorder: A systematic review and dose-related network meta-analysis across different age groups

Michele Fornaro, Chiara Di Lorenzo, Federico Manuel Daray, Taro Kishi

Journal of Affective Disorders · 2026-08 · 407 · 121798

DOI: 10.1016/j.jad.2026.121798 ↗

Kurz gefasst

Netzwerk-Metaanalyse in der Zeitschrift Journal of Affective Disorders, 2026-08. Verfasst von Michele Fornaro und 3 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Treatment-Resistant Psychosis, Section of Psychiatry, Department of Neuroscience, Reproductive Science and Dentistry, University School of Me…. Hauptthemen laut MEDLINE: Bipolar Disorder, Antipsychotic Agents, Antimanic Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Bipolar disorder (BD) is a chronic mental illness that requires lifelong treatment. We investigated the comparative efficacy and safety of pharmacological interventions for bipolar maintenance, considering dose effects across different age groups. METHODS: We conducted a network meta-analysis (NMA) of randomized controlled trials (RCTs) comparing pharmacological interventions against each other or placebo for the maintenance of BD, searching for records indexed in PubMed/MEDLINE, Embase, Web of Science, and Scopus (from inception through 2026.1.12). Co-primary outcomes were the relapse rate (into an acute episode of any mood polarity) and tolerability (discontinuation due to side effects). Relapse into episodes of specific mood polarities (namely, depressive/manic/mixed polarity), acceptability (discontinuation due to any cause), and rate of specific adverse events were secondary outcomes. Confidence-In-Network-Meta-Analysis was likewise appraised. RESULTS: Forty-four RCTs involving 23 distinct treatment combinations encompassed 10,867 participants. Sensitivity analysis retaining only low-risk-of-bias studies and excluding outliers for possible effect modifiers indicated that asenapine 20 mg/day, aripiprazole 20 mg/day, 30 mg/day, quetiapine 300 mg/day, 600 mg/day and 550 mg/day, lithium 800 mg/day, lurasidone 80 mg/day, carbamazepine 400 mg/day and 650 mg/day, valproate 71-125 μg/mL, olanzapine 20 mg/day, long-acting aripiprazole 400 mg/4 weeks, long-acting risperidone 25 mg/2 weeks, aripiprazole 30 mg/day+lamotrigine 200 mg/day outperformed placebo. Several additional drugs might be efficacious, although they either emerged as outliers for the mean age of participants/proportion of females/proportion of BD-I/II patients, baseline severity of mania/depression, and trial duration. CONCLUSIONS: Our findings are consistent with previous NMAs and current guidelines, yet they expand current knowledge by concurrently appraising different drugs, doses, and age groups.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bipolar DisorderAntipsychotic AgentsAntimanic AgentsHumansDose-Response Relationship, DrugRandomized Controlled Trials as TopicAge FactorsAripiprazole

Stichwörter der Autor:innen

AdultBipolar disorderMaintenanceNetwork meta-analysisPediatricPharmacotherapy

Substanzen

Antipsychotic AgentsAntimanic AgentsAripiprazole

Autor:innen und Institutionen

  • Unit of Treatment-Resistant Psychosis, Section of Psychiatry, Department of Neuroscience, Reproductive Science and Dentistry, University School of Medicine of Naples Federico II, Naples, Italy. Electronic address: dott.…
  • Federico II University of Naples, Naples, Italy.
  • Faculty of Medicine, School of Medicine, Institute of Pharmacology, University of Buenos Aires, Buenos Aires, Argentina; Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno (CEMIC) - National Scientifi…
  • Department of Psychiatry, Fujita Health University School of Medicine, Toyoake, Aichi, 470-1192, Japan.

Zitieren

APA

Fornaro, M., Di Lorenzo, C., Daray, F. M., & Kishi, T. (2026). Efficacy and safety of pharmacological interventions for the maintenance of bipolar disorder: A systematic review and dose-related network meta-analysis across different age groups. Journal of Affective Disorders, 407, 121798. https://doi.org/10.1016/j.jad.2026.121798

Vancouver

Fornaro M, Di Lorenzo C, Daray FM, Kishi T. Efficacy and safety of pharmacological interventions for the maintenance of bipolar disorder: A systematic review and dose-related network meta-analysis across different age groups. Journal of Affective Disorders. 2026;407:121798. doi:10.1016/j.jad.2026.121798

BibTeX
@article{Fornaro2026,
  author = {Fornaro, Michele and Di Lorenzo, Chiara and Daray, Federico Manuel and Kishi, Taro},
  title = {Efficacy and safety of pharmacological interventions for the maintenance of bipolar disorder: A systematic review and dose-related network meta-analysis across different age groups},
  journal = {Journal of Affective Disorders},
  year = {2026},
  volume = {407},
  pages = {121798},
  doi = {10.1016/j.jad.2026.121798}
}
Kostenlos starten →